Skip to content

A randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markers

A randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markers

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037391
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A on C

Interventions

Sponsors

Shanghai Municipal Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the diagnostic criteria of ckd2-4 and grade 1-2 of acute kidney injury; 2. Patients who meet the TCM syndrome diagnostic criteria of spleen and kidney deficiency and toxin and blood stasis syndrome; 3. 24h U-pro <= 2.5g; 4. Patients aged from 18 to 75 years old; 5. Patients voluntarily participate in the clinical trial and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women or women preparing for pregnancy and lactation; 2. Patients with severe primary diseases of other organs and in urgent need of immediate treatment, or with consumptive system diseases such as malignant tumor and active tuberculosis; 3. Patients after renal transplantation; 4. Patients with mental illness and those who can't cooperate with each other; 5. Patients who are allergic to treatment drugs; 6. Patients who are participating in other drug clinical trials or have participated in other clinical trials within 3 months.

Design outcomes

Primary

MeasureTime frame
Serum creatinine;Blood urea nitrogen;eGFR;24h U-pro;Acr;IL-6;TNF-a;MDA;SOD;Blood potassium;the syndrome scores of TCM;

Countries

China

Contacts

Public ContactGong Xuezhong

Shanghai Municipal Hospital of Traditional Chinese Medicine

2071425786@qq.com+86 21-56639828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026